| 55 |
Correction: Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studiesCritical Care |
Department of Chest Diseases |
2023 |
| 56 |
Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer’s-like pathology and symptoms through multiple targeting actions in aged T2D rats |
Department of Pharmacology |
2023 |
| 57 |
Prognostic value of echocardiographic indices in risk stratification of intermediate‑risk pulmonary embolism |
Department of Chest Diseases |
2023 |
| 58 |
The anti-inflammatory effects of atorvastatin upon the outcome of traumatic brain injury patients: A randomized-controlled double-blind clinical trial |
Department of Anesthesia and Intensive Care |
2023 |
| 59 |
Peripheral Mononuclear Cells Surface Markers Evaluation in Different Stages of Hepatocellular Carcinoma; in a Trial for Early and Accurate Diagnosis in Patients with Post-Hepatitis Liver Cirrhosis and Unremarkable Raised AFP |
Department of Microbiology and Immunology |
2023 |
| 60 |
Validity of serum zinc/copper ratio as a potential novel biomarker in childhood epilepsy |
Department of Biochemistry |
2023 |
| 61 |
Effect of aflatoxin b1 on the haematology, testes, and lungs of adult male rats: a physiological and histological study |
Department of Medical Physiology |
2023 |
| 62 |
Detection of Pattern of Some Unusual Signs and Symptoms of Multiple Sclerosis |
Department of Neurology and Psychiatry |
2023 |
| 63 |
Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study |
Department of Dermatology, Venereology and Andrology |
2023 |
